LGLFX
Price
$60.13
Change
+$0.82 (+1.38%)
Updated
Oct 8 closing price
Net Assets
8.13B
RGACX
Price
$86.09
Change
+$0.64 (+0.75%)
Updated
Oct 8 closing price
Net Assets
340.58B
Interact to see
Advertisement

LGLFX vs RGACX

Header iconLGLFX vs RGACX Comparison
Open Charts LGLFX vs RGACXBanner chart's image
Lord Abbett Growth Leaders F
Price$60.13
Change+$0.82 (+1.38%)
VolumeN/A
Net Assets8.13B
American Funds Growth Fund of Amer R3
Price$86.09
Change+$0.64 (+0.75%)
VolumeN/A
Net Assets340.58B
LGLFX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
LGLFX vs. RGACX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGLFX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 341B vs. LGLFX (8.13B). RGACX pays higher dividends than LGLFX: RGACX (0.07) vs LGLFX (0.00). LGLFX was incepted earlier than RGACX: LGLFX (14 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than LGLFX (0.75). LGLFX is a more actively managed with annual turnover of: 94.00 vs. RGACX (25.00). LGLFX has a lower initial minimum investment than RGACX: LGLFX (0) vs RGACX (250). LGLFX annual gain was more profitable for investors over the last year : 33.88 vs. RGACX (14.19). RGACX return over 5 years is better than : 40.04 vs. LGLFX (28.57).
LGLFXRGACXLGLFX / RGACX
Total Expense Ratio0.650.9469%
Annual Report Gross Expense Ratio0.750.9480%
Fund Existence14 years23 years-
Gain YTD20.47519.586105%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets8.13B341B2%
Annual Yield % from dividends0.000.07-
Returns for 1 year33.8814.19239%
Returns for 3 years120.8974.27163%
Returns for 5 years28.5740.0471%
Returns for 10 years158.54101.32156%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATXS8.400.93
+12.45%
Astria Therapeutics
SCNI1.630.17
+11.64%
Scinai Immunotherapeutics Ltd.
KLIC40.730.68
+1.70%
Kulicke and Soffa Industries
UCL2.30N/A
N/A
uCloudlink Group
HTHT37.78-0.28
-0.74%
H World Group Limited